Fiche d'information compilée à partir de PubMed
Cette fiche a été compilée à partir de résumés PubMed (NIH) avec l'assistance d'une IA. Chaque affirmation factuelle est citée par un article PubMed réel (voir la liste des sources). Elle n'a pas encore été révisée par un humain — confirmez auprès d'un professionnel de santé avant utilisation.
Compilé à partir de 30 articles PubMed · modèle : gemma4:31b
Résumé
Contexte
Usages traditionnels
Composés actifs
Mécanisme d'action
Preuves cliniques
A trial of the Kampo formula daiobotanpito (containing rhubarb) combined with antibiotics showed no significant difference in treatment success rates compared to placebo, although the treatment group showed a significant reduction in hospitalization days [PMID:40595170].
An ethanolic extract of R. tanguticum inhibited several H1N1 subtypes by blocking viral attachment, penetration, and virus-endosome fusion [PMID:27302738].
Chrysophanein extracted from R. tanguticum ameliorated symptoms and repaired mucosal barrier integrity in mouse models [PMID:40992441].
R. tanguticum is noted to show a significant decrease in neuronal injury via mechanisms such as increasing superoxide dismutase and catalase activities [PMID:31206893].
Synthèse des preuves
Sources PubMed
- 1.PMID: 37814999 (2024) — Exploration of plant metabolomics variation and absorption characteristics of water-extracted Rheum tanguticum and ethanol-extracted Rheum tanguticum by UHPLC-Q-TOF-MS/MS. · Phytochemical analysis : PCA
- 2.PMID: 36445877 (2022) — Comparative study of the Rheum tanguticum's chemical contents based on spatial distribution characteristics. · PloS one
- 3.PMID: 41158982 (2025) — Rhubarb: Traditional Uses, Phytochemistry, Multiomics-Based Novel Pharmacological and Toxicological Mechanisms. · Drug design, development and therapy
- 4.PMID: 34629100 (2021) — Advances in the study of emodin: an update on pharmacological properties and mechanistic basis. · Chinese medicine
- 5.PMID: 26357619 (2014)